tempo has been researched along with Cystic-Fibrosis* in 1 studies
1 other study(ies) available for tempo and Cystic-Fibrosis
| Article | Year |
|---|---|
Exploring the impact of elexacaftor-tezacaftor-ivacaftor treatment on opinions regarding airway clearance techniques and nebulisers: TEMPO a qualitative study in children with cystic fibrosis, their families and healthcare professionals.
Semistructured qualitative interviews were performed with 10 children with CF, 7 parents/carers and 10 HCPs. Audio recordings were transcribed and analysed using reflexive thematic analysis.. Four main themes were identified: 'Kaftrio changed my life', 'Your entire life is dictated by the CF timetable', 'Simplifying treatment-hopes and fears' and 'Kaftrio is a game-changer' along with several subthemes and an overarching theme of 'I still can't get my head around how three tablets can do what Kaftrio done'.. Despite the highly positive impact of ETI on the health of children with CF some concerns remain about the longer-term outcomes of reducing ACTs or nebulised treatments. ETI has prompted a shift in treatment for many and offers an opportunity to personalise approaches. Topics: Aged; Aminophenols; Benzodioxoles; Child; Cyclic N-Oxides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Delivery of Health Care; Humans; Indoles; Mutation; Nebulizers and Vaporizers; Pyrazoles; Pyridines; Pyrrolidines; Quinolones | 2022 |